Roca Josep, Cano Isaac, Gomez-Cabrero David, Tegnér Jesper
IDIBAPS, Hospital Clínic, CIBERES, Universitat de Barcelona, Villarroel, 170, Barcelona, Catalunya, 08036, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Bunyola, Balearic Islands.
Methods Mol Biol. 2016;1386:283-303. doi: 10.1007/978-1-4939-3283-2_13.
Systems medicine, using and adapting methods and approaches as developed within systems biology, promises to be essential in ongoing efforts of realizing and implementing personalized medicine in clinical practice and research. Here we review and critically assess these opportunities and challenges using our work on COPD as a case study. We find that there are significant unresolved biomedical challenges in how to unravel complex multifactorial components in disease initiation and progression producing different clinical phenotypes. Yet, while such a systems understanding of COPD is necessary, there are other auxiliary challenges that need to be addressed in concert with a systems analysis of COPD. These include information and communication technology (ICT)-related issues such as data harmonization, systematic handling of knowledge, computational modeling, and importantly their translation and support of clinical practice. For example, clinical decision-support systems need a seamless integration with new models and knowledge as systems analysis of COPD continues to develop. Our experience with clinical implementation of systems medicine targeting COPD highlights the need for a change of management including design of appropriate business models and adoption of ICT providing and supporting organizational interoperability among professional teams across healthcare tiers, working around the patient. In conclusion, in our hands the scope and efforts of systems medicine need to concurrently consider these aspects of clinical implementation, which inherently drives the selection of the most relevant and urgent issues and methods that need further development in a systems analysis of disease.
系统医学运用并改编系统生物学中已开发的方法和途径,有望在临床实践和研究中实现及应用个性化医疗的持续努力中发挥关键作用。在此,我们以慢性阻塞性肺疾病(COPD)的研究为例,回顾并批判性地评估这些机遇与挑战。我们发现,在如何解析疾病发生和发展过程中产生不同临床表型的复杂多因素成分方面,存在重大尚未解决的生物医学挑战。然而,虽然对COPD的这种系统理解是必要的,但还存在其他辅助性挑战,需要与COPD的系统分析协同解决。这些挑战包括与信息和通信技术(ICT)相关的问题,如数据协调、知识的系统处理、计算建模,以及重要的是它们对临床实践的转化和支持。例如,随着COPD系统分析的不断发展,临床决策支持系统需要与新模型和知识无缝集成。我们在针对COPD的系统医学临床实施方面的经验凸显了管理变革的必要性,包括设计适当的商业模式以及采用ICT,以提供并支持跨医疗层级围绕患者工作的专业团队之间的组织互操作性。总之,在我们看来,系统医学的范围和努力需要同时考虑临床实施的这些方面,这本质上推动了在疾病系统分析中选择最相关且最紧迫的问题和需要进一步发展的方法。